Medivation (MDVN)

Medivation (MDVN)

Postby winston » Tue Nov 06, 2012 6:41 am

not vested

Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe.

The companys lead development candidate includes MDV3100, a molecule, which is in Phase-III development for the treatment of castration-resistant prostate cancer.

Medivation, Inc. has collaboration with Astellas for the development, manufacture, and commercialization of MDV3100 for the treatment of prostate cancer.

The company was founded in 2003 and is headquartered in San Francisco, California.

http://todaysbigstock.com/2012/11/05/me ... sdaq-mdvn/
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Return to L to R

Who is online

Users browsing this forum: No registered users and 7 guests